AUDENTES THERAPEUTICS INC's ticker is BOLD and the CUSIP is 05070R104. A total of 89 filers reported holding AUDENTES THERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $421,000 | -51.9% | 14,982 | -35.2% | 0.00% | 0.0% |
| Q2 2019 | $875,000 | -21.1% | 23,122 | -18.6% | 0.00% | -50.0% |
| Q1 2019 | $1,109,000 | +81.2% | 28,422 | -1.0% | 0.00% | +100.0% |
| Q4 2018 | $612,000 | -75.1% | 28,722 | -53.7% | 0.00% | -75.0% |
| Q3 2018 | $2,455,000 | +8.5% | 62,022 | +4.7% | 0.00% | +33.3% |
| Q2 2018 | $2,263,000 | +51.8% | 59,222 | +19.3% | 0.00% | +50.0% |
| Q1 2018 | $1,491,000 | +2.2% | 49,622 | +6.3% | 0.00% | 0.0% |
| Q4 2017 | $1,459,000 | +107.0% | 46,690 | +85.4% | 0.00% | +100.0% |
| Q3 2017 | $705,000 | +45.7% | 25,180 | -0.4% | 0.00% | 0.0% |
| Q2 2017 | $484,000 | +15.0% | 25,280 | +2.4% | 0.00% | 0.0% |
| Q1 2017 | $421,000 | +117.0% | 24,682 | +132.8% | 0.00% | – |
| Q4 2016 | $194,000 | +1.6% | 10,600 | -0.9% | 0.00% | – |
| Q3 2016 | $191,000 | – | 10,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 2,485,000 | $69,804,000 | 6.41% |
| Versant Venture Management, LLC | 553,916 | $15,559,500,000 | 6.02% |
| Foresite Capital Management III, LLC | 315,331 | $8,858,000 | 3.38% |
| Opaleye Management Inc. | 285,000 | $8,006,000 | 2.90% |
| Redmile Group, LLC | 2,962,655 | $83,221,000 | 2.78% |
| Casdin Capital, LLC | 860,000 | $24,157,400,000 | 2.50% |
| Sofinnova Investments, Inc. | 933,640 | $26,226,000 | 2.37% |
| Eversept Partners, LP | 253,726 | $7,127,163 | 2.21% |
| PFM Health Sciences, LP | 2,315,938 | $65,055,000 | 1.92% |
| Global Endowment Management, LP | 581,488 | $16,334,000 | 1.43% |